Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identificadores![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identificadores
URI: http://hdl.handle.net/20.500.11940/7866
PMID: 24457911
DOI: 10.1038/bjc.2013.831
ISSN: 0007-0920
Fecha de publicación
2014Título de revista
BRITISH JOURNAL OF CANCER
Tipo de contenido
Artigo
![](/xmlui/themes/Mirage2//images/final_lines.png)